Response adapted oncologic surgery following neoadjuvant immunotherapy and chemotherapy for resectable locally advanced oral cavity and oropharyngeal squamous cell carcinoma.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e18107
Abstract: e18107 Background: Head and neck squamous cell carcinoma (SCC) is the seventh leading cause of cancer worldwide. For patients (pts) with oral cavity and oropharyngeal SCC (OSCC), surgery is the mainstay of treatment, but in… read more here.
Keywords: surgery; disease; adapted oncologic; response ... See more keywords